Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.
View stock
VS
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
View stock

Stock highlights

Stock comparison highlights
Stock name
VolitionRXJohnson & Johnson
Last price
$0.18$255.56
Currency
USD
USD
$2.6M$616B
-38.81
-$3.80$6.58
1.090.21
0$5.28
02.10%
Sector
HealthHealth
Employees
57138,200
Ticker
$VNRX$JNJ
Primary listing
AMEXNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in $VNRX or $JNJ on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.